The Effect of Disease Modifying Therapies on Disability Progression in Multiple Sclerosis: A Systematic Overview of Meta-Analyses

Background: Disease modifying therapy (DMT) efficacy trials make an essential contribution to the development of evidence-based clinical treatments and practices for people with multiple sclerosis (MS). Meta-analysis is a critical part of this process and provides a powerful tool to assess the effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Claflin, Suzi B., Broadley, Simon, Taylor, Bruce V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335290/
https://www.ncbi.nlm.nih.gov/pubmed/30687214
http://dx.doi.org/10.3389/fneur.2018.01150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335290/
https://www.ncbi.nlm.nih.gov/pubmed/30687214
http://dx.doi.org/10.3389/fneur.2018.01150

Ejemplares similares